SELLAS Life Sciences (SLS) Change in Cash (2010 - 2026)

SELLAS Life Sciences (SLS) has 17 years of Change in Cash data on file, last reported at $35.3 million in Q1 2026.

• On a quarterly basis, Change in Cash rose 143.29% year-over-year to $35.3 million in Q1 2026; TTM through Mar 2026 was $78.7 million, a 688.42% increase from a year earlier, with the FY2025 full-year figure at $57.9 million, up 409.92% from the prior year.
• Change in Cash for Q1 2026 stood at $35.3 million, up from $27.5 million in the prior quarter.
• Over the last five years, Change in Cash for SLS reached as high as $35.3 million in Q1 2026 and fell as low as -$10.1 million in Q2 2023.
• Historically, Change in Cash has averaged $5.0 million across 5 years, with a median of -$1.4 million in 2023.
• Across the five-year window, Change in Cash soared 575.96% in 2022 and slumped 396.53% in 2024, its largest moves.
• Year by year, Change in Cash stood at -$4.2 million in 2022, then soared by 65.92% to -$1.4 million in 2023, then tumbled by 396.53% to -$7.1 million in 2024, then surged by 484.51% to $27.5 million in 2025, then gained by 28.5% to $35.3 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were $35.3 million in Q1 2026, $27.5 million in Q4 2025, and $19.0 million in Q3 2025.